inHEART represents a groundbreaking advancement in the field of cardiac healthcare, leveraging artificial intelligence to create a digital twin of the heart. This innovative solution offers unparalleled anatomical insights, enabling healthcare professionals to visualize and understand the intricate details of heart structures with unprecedented clarity. By analyzing CT and MR images through its proprietary segmentation algorithm, inHEART constructs detailed 3D cardiac models that reveal tissue and structural characteristics, facilitating optimized treatment strategies for patients with heart rhythm disorders.
The platform's ability to provide a comprehensive view of each patient's unique anatomy before the procedure begins significantly reduces the need for intraprocedural planning. This allows physicians to focus more on delivering effective therapy during the procedure, thereby enhancing clinical outcomes. inHEART's seamless integration into electroanatomic mapping system (EAM) systems ensures compatibility with all major EAM platforms, making it a versatile tool in the electrophysiology lab.
Clinical studies have demonstrated that inHEART can reduce procedure times by up to 60% and decrease the recurrence of ventricular tachycardia (VT) by 38%. These improvements in efficiency and success rates underscore the value of image-guided VT ablations over conventional methods. Testimonials from leading cardiac electrophysiologists highlight the platform's impact on simplifying and enhancing VT ablation therapy, with many noting the invaluable precision and accuracy it brings to targeting arrhythmogenic areas in scar tissue.
inHEART's commitment to advancing cardiac care is further evidenced by its recent collaborations and funding achievements. The partnership with Circle Cardiovascular Imaging aims to distribute the AI-driven digital twin of the heart globally, while the 750k€ funding from SWEN Capital Partners will accelerate the development of inHEART's 3D imaging platform. These milestones reflect the growing recognition of inHEART's potential to transform the diagnosis and treatment of heart rhythm disorders, offering hope for improved patient outcomes worldwide.
